QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Alzheimers sjukdom och det Svenska samhället
Anders Gustavsson, partner vid Quantify, och professor Bengt Winblad vid Karolinska institutet har skrivit rapporten Alzheimers sjukdom – en utmaning för Sverige. Läs den här: Alzheimers sjukdom – en utmaning för Sverige 20210701. Rapporten syftar till att ge en översiktlig bild av kunskapsläget kring Alzheimers sjukdom, hur den påverkar oss i Sverige och vad som görs för att hantera den stora samhällsutmaning som sjukdomen innebär idag och i […]
Happy international Pride month!
At Quantify Research, we support equality and diversity, and to honor pride month we want to highlight the work of our Lead Analyst, Christoph Abé, who recently published a large-scale imaging-genetics study on sexual orientation and the brain. Hopefully, the results can help promote equality, contribute to de-stigmatization efforts, and in turn improve mental health outcomes in the LGBTQ community.
Non-heterosexual sexual […]
Quantify poster presented at ECFS2021
The poster “Clinical Outcomes in People With Cystic Fibrosis Treated With Lumacaftor/Ivacaftor in Routine Clinical Practice in Sweden”, co-authored by Quantify’s Martina Aldvén, Jonas Banefelt and Fredrik Borgström was presented at the ECFS 44th European Cystic Fibrosis Conference last week.
#ECFS2021 #CysticFibrosis #ECFSgoesDigital
10 June – International NASH Day
June 10 was the International #NASHday, this year with the theme NASH Around the World. Quantify is actively engaging in retrospective research in the field of chronic liver disease, and Non-alcoholic Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH), in particular. Quantify has therefore initiated a large retrospective study, HEalth outcomes and Risk Assessment […]